Neuralink's first patient speaks about how Elon Musk's brain implant changed his life #technology
Neuralink's first patient told Bloomberg Businessweek how Elon Musk's brain implant has changed his life. In this episode of the Elon, Inc. podcast, Ashlee Vance discusses what the future may be like for Musk's startup and its patient
Read more: https://trib.al/TZYOzSs
Get more here: https://www.bloomberg.com/elon-inc-podcast?sref=hT7i0Nd8
Last week, Bloomberg Businessweek published an exclusive look at Noland Arbaugh, the first person to get Elon Musk’s Neuralink technology implanted in his head. Our own Ashlee Vance spent time with Arbaugh, who lives with his parents and (as you’ll hear) some vocal farm animals. Vance joins us to talk about what he learned from the first patient in Neuralink’s inaugural clinical trial. He is joined by Bloomberg’s Sarah McBride to give a full picture on what it all means. Plus, we talk to markets reporter Kiel Porter and space reporter Loren Grush about all of the action around SpaceX stock—which is kind of interesting since it’s still a private company.
Neuralink’s first patient told Bloomberg Businessweek how Elon Musk’s brain implant has changed his life. In this episode of the Elon, Inc. podcast, Ashlee Vance discusses what the future may be like for Musk’s startup and its patient
Read more: https://trib.al/TZYOzSs
Get more here: https://www.bloomberg.com/elon-inc-podcast?sref=hT7i0Nd8
Last week, Bloomberg Businessweek published an exclusive look at Noland Arbaugh, the first person to get Elon Musk’s Neuralink technology implanted in his head. Our own Ashlee Vance spent time with Arbaugh, who lives with his parents and (as you’ll hear) some vocal farm animals. Vance joins us to talk about what he learned from the first patient in Neuralink’s inaugural clinical trial. He is joined by Bloomberg’s Sarah McBride to give a full picture on what it all means. Plus, we talk to markets reporter Kiel Porter and space reporter Loren Grush about all of the action around SpaceX stock—which is kind of interesting since it’s still a private company.
